NASDAQ:MIRM

Mirum Pharmaceuticals Stock Predictions

Healthcare > Biotechnology

Buy MIRM

*Your capital is at risk

$91.84

-0.335 (-0.363%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

MIRM Prediction Chart

MIRM Predictions History

Latest community submissions for MIRM.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Jan 18, 2022	$18.28 -0.44%	$18.36	X	99.56%	5
deglees78.293557	Jan 18, 2022	Bullish	$18.36	X	—	0
JS Pro	Sep 21, 2021	$19.21 +0.58%	$19.10	X	99.42%	4
JS Pro	Jun 10, 2021	$16.78 -2.33%	$17.18	X	97.67%	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for MIRM with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT MIRUM PHARMACEUTICALS, INC.

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment o...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	18.86%	May 06
GLBE $31.61	5.35%	May 05
SAP $172.39	10.69%	May 05
W WCLD $27.34	27.18%	Apr 29
ADBE $243.57	7.61%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by